Also read: 5 Diabetes Myths Debunked MYTH: All Prescription Weight Loss Medications Are the Same
Spotting Between Periods: Small vaginal bleeding or spotting may happen when the body is getting used to receiving new hormone levels from Semaglutide treatment and is thus the reason for the mid-cycle bleeding
Your doctor will start you on a low dose and slowly raise it if your body tolerates the medication
(2024, September) Retatrutide is a novel triple-agonist targeting GLP-1, GIP, and glucagon receptors, showing in phase 2 trials that it can deliver remarkably large weight losses (up to ~24% over 48 weeks in people with obesity) along with strong improvements in HbA1c, lipid profiles, liver fat (in NAFLD), insulin sensitivity, and other cardiometabolic markers
Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
The cumulative incidence was 6.7% for semaglutide versus 0.8% for the non-GLP-1 RA group over 36 months